Farther Finance Advisors’s GeoVax Labs GOVX Stock Holding History

Farther Finance Advisors’s Portfolio GOVX Stock Details GOVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-20	Closed	-$84	–	5815
2025 Q4	$84	Hold	20	–	–	﹤0.01%	5313
2025 Q3	$234	Hold	20	–	–	﹤0.01%	4692
2025 Q2	$428	Buy	+20	New	+$498	﹤0.01%	4067

Other funds holding GOVX

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Farther Finance Advisors's GOVX Position: Q1 2026 in Review

Farther Finance Advisors sold out of GeoVax Labs (GOVX) in Q1 2026, closing a stake of 20 shares — an estimated $84 sold.

Farther Finance Advisors first reported a position in GOVX in Q2 2025 and held it in 3 quarters. The position peaked at $428 in Q2 2025. 16 funds tracked by Wall St. Rank hold GOVX as of Q1 2026.

Farther Finance Advisors reported no remaining GeoVax Labs position as of Q1 2026 after selling out during the quarter.
Farther Finance Advisors sold 20 GeoVax Labs shares in Q1 2026, an estimated $84.
Farther Finance Advisors first reported a position in GeoVax Labs in Q2 2025 and held it in 3 quarters.
Farther Finance Advisors's GeoVax Labs position peaked at $428 in Q2 2025.
16 funds tracked by Wall St. Rank held GeoVax Labs as of Q1 2026.

Based on Farther Finance Advisors's 13F filing for Q1 2026, filed 7 Apr 2026.